Elanco Animal Health Incorporated (ELAN)

USD 11.73

(-4.71%)

Net Income Summary of Elanco Animal Health Incorporated

Elanco Animal Health Incorporated's latest annual net income in 2023 was -1.23 Billion USD , down -1563.51% from previous year.
Elanco Animal Health Incorporated's latest quarterly net income in 2024 Q2 was -50 Million USD , down -256.25% from previous quarter.
Elanco Animal Health Incorporated reported an annual net income of -74 Million USD in 2022, up 84.32% from previous year.
Elanco Animal Health Incorporated reported an annual net income of -472 Million USD in 2021, up 15.73% from previous year.
Elanco Animal Health Incorporated reported a quarterly net income of -50 Million USD for 2024 Q2, down -256.25% from previous quarter.
Elanco Animal Health Incorporated reported a quarterly net income of -97 Million USD for 2023 Q2, down -194.17% from previous quarter.

Annual Net Income Chart of Elanco Animal Health Incorporated (2023 - 2015)

Historical Annual Net Income of Elanco Animal Health Incorporated (2023 - 2015)

Year	Net Income	Net Income Growth
2023	-1.23 Billion USD	-1563.51%
2022	-74 Million USD	84.32%
2021	-472 Million USD	15.73%
2020	-560.1 Million USD	-924.89%
2019	67.9 Million USD	-21.5%
2018	86.5 Million USD	127.84%
2017	-310.7 Million USD	-548.64%
2016	-47.9 Million USD	77.28%
2015	-210.8 Million USD	0.0%

Year	Net Income	Net Income Growth
2024 Q1	32 Million USD	122.7%
2024 Q2	-50 Million USD	-256.25%
2023 Q2	-97 Million USD	-194.17%
2023 Q4	-141 Million USD	87.14%
2023 FY	-1.23 Billion USD	-1563.51%
2023 Q3	-1.09 Billion USD	-1029.9%
2023 Q1	103 Million USD	290.74%
2022 Q4	-54 Million USD	-10.2%
2022 FY	-74 Million USD	84.32%
2022 Q3	-49 Million USD	-122.73%
2022 Q2	-22 Million USD	-143.14%
2022 Q1	51 Million USD	152.58%
2021 Q3	-104 Million USD	50.48%
2021 FY	-472 Million USD	15.73%
2021 Q4	-97 Million USD	6.73%
2021 Q1	-61 Million USD	81.1%
2021 Q2	-210 Million USD	-244.26%
2020 Q3	-135 Million USD	-153.76%
2020 Q4	-322.8 Million USD	-139.11%
2020 FY	-560.1 Million USD	-924.89%
2020 Q1	-49.1 Million USD	-416.84%
2020 Q2	-53.2 Million USD	-8.35%
2019 Q4	-9.5 Million USD	-195.0%
2019 Q3	10 Million USD	-72.14%
2019 Q2	35.9 Million USD	13.97%
2019 FY	67.9 Million USD	-21.5%
2019 Q1	31.5 Million USD	92.07%
2018 Q4	16.4 Million USD	-72.76%
2018 FY	86.5 Million USD	127.84%
2018 Q3	60.2 Million USD	195.86%
2018 Q2	-62.8 Million USD	-186.38%
2018 Q1	72.7 Million USD	145.02%
2017 Q1	-64.25 Million USD	0.0%
2017 Q4	-161.5 Million USD	-680.19%
2017 Q2	-64.25 Million USD	0.0%
2017 Q3	-20.7 Million USD	67.78%
2017 FY	-310.7 Million USD	-548.64%
2016 FY	-47.9 Million USD	77.28%
2015 FY	-210.8 Million USD	0.0%

Peer Net Income Comparison of Elanco Animal Health Incorporated

Name	Net Income	Net Income Difference
Amneal Pharmaceuticals, Inc.	-83.99 Million USD	-1365.598%
Bausch Health Companies Inc.	-592 Million USD	-107.939%
Catalent, Inc.	-1.04 Billion USD	-18.025%
Emergent BioSolutions Inc.	-760.5 Million USD	-61.867%
Perrigo Company plc	-12.7 Million USD	-9592.913%
Teva Pharmaceutical Industries Limited	-559 Million USD	-120.215%
Zoetis Inc.	2.34 Billion USD	152.517%